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Introduction
Exercise prescription is an important adjunct to medical 
management in the treatment of cardiometabolic diseases.1 
While the traditional approach of prescribing moderate-inten-
sity continuous exercise has been associated with improved 
health outcomes and a low incidence of adverse events,2 there 
is growing evidence for a dose–response relationship between 
exercise intensity and all-cause mortality, suggesting that 
higher-intensity exercise may afford greater benefit.3 However, 
this needs to be balanced against the increased risk of adverse 
responses with acute high-intensity exercise,4 which is espe-
cially relevant for individuals with cardiometabolic diseases.
The guidelines of the American College of Sports Medi-
cine,1 the American Heart Association,5,6 and the Exercise and 
Sports Science Australia7 for exercise prescription recommend 
moderate aerobic exercise (40%–60% of peak aerobic power, 
VO2peak) for most patients (outpatients) with cardiovascular 
disease (CVD), while the same organizations recommend up 
to vigorous-intensity aerobic exercise (84% of VO2 reserve or 
heart rate reserve and 70%–89% maximal heart rate, HRmax) 
in patients with type 2 diabetes mellitus (T2DM).8–10
Despite the well-documented benefits from exercise 
training for patients with cardiometabolic diseases, 60% of 
adults11 and up to 77% of adults with T2DM12 do not meet 
the minimum-recommended level of physical activity (at least 
30 minutes of moderate-intensity aerobic exercise most days 
of the week). Lack of time is cited as one of the main barriers 
for participation in exercise programs.13,14 Novel approaches to 
exercise prescription have therefore been developed to reduce the 
time required to achieve health and fitness benefits. One such 
exercise prescription strategy is high-intensity interval exercise 
(HIIE), which involves brief bursts of intense exercise (usually 
$90% of VO2peak) interspersed by periods of rest/low-intensity 
exercise. This contrasts with the longer-duration, continuous 
moderate-to-vigorous exercise intensity (,85% of VO2peak) tra-
ditionally applied.15
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HIIE training has been shown to improve a broad range 
of cardiovascular risk factors, including VO2peak,16,17 insulin 
sensitivity and glycemic control,18,19 high-density lipopro-
tein levels,20 body mass index and waist circumference,20 sys-
tolic and diastolic blood pressure,21 and left ventricular (LV) 
structure and function,16 although not in all cases.17,22,23 For 
comprehensive reviews of the effects of HIIE training on 
clinical and physiological outcomes, refer Kessler et al.15, 
Gibala et al.24, Weston et al.25, and Hawley and Gibala.26 
Importantly, several studies have found that HIIE produces 
superior physical, clinical, and functional benefits compared 
to moderate-intensity continuous exercise (MICE),16,27 rais-
ing the question of whether HIIE should be utilized more 
broadly in clinical practice. To date, there are ongoing con-
cerns about the safety of HIIE, which need to be evaluated 
before recommendations can be made regarding its use in 
clinical exercise programs.
While a recent study found that significant adverse 
responses (cardiac arrest or myocardial infarction [MI]) 
occurred rarely during HIIE in individuals with cardio-
metabolic diseases (1 event per 23,182 hours of exercise), 
this was more frequent than that observed during MICE 
(1 event per 129,456 hours of exercise).28 The acute car-
diovascular response to a session of HIIE may under-
lie this discrepancy in event rates; however, a systematic 
review of the cardiovascular response during, as well as the 
associated event rates of, HIIE is yet to be undertaken in 
patients with cardiometabolic disease One previous review 
has examined whether high-intensity interval training 
should be included in the exercise rehabilitation of patients 
with chronic heart failure (CHF).29 However, this review 
focused only on CHF and only three articles were included 
in the review. A second review3 examined the effects of 
intermittent exercise, not HIIE, versus continues exercise 
in patients with CHF. The intensities were varied and the 
focus was not on high-intensity exercise. Accordingly, the 
purpose of the current review is to examine the published 
literature to determine the incidence of adverse responses 
during or immediately following a single session of HIIE 
in people with cardiometabolic diseases to assess its safety 
and appropriateness for inclusion in exercise programs for 
this population group.
Materials and Methods
The review was conducted based on the guidelines set out by 
the Preferred Reporting Items for Systematic reviews and 
Meta-Analyses (PRISMA) statement.30
search strategy. Medline, Embase, and CINAHL 
electronic databases were searched for exercise trials ending 
January 2015, using the search strategy described in detail in 
Supplementary Table 1. In brief, keyword and category-based 
searches (including full terms and abbreviations) were per-
formed, which included the following: (i) exercise type: high-
intensity interval training and high-intensity intermittent 
training, HIIE, and high-intensity intermittent exercise, 
interval training, interval exercise, repeated sprint training, 
and sprint interval training; (ii) intensity: high-intensity 
or vigorous exercise/training; and (iii) duration: acute bout, 
single bout, and exercise training. Categories (i)–(iii) were 
also combined using “AND”, limited to humans, reported 
in English, and performed in adults aged $18 years. In 
addition, reference lists of publications meeting the inclu-
sion criteria were manually searched to identify any relevant 
studies not found through electronic searches. At least two 
authors independently assessed the suitability of each study 
for inclusion.
Inclusion and exclusion criteria. Studies with the fol-
lowing criteria were included: (i) the study’s cohort had one 
or more of the following conditions/diseases: CVD includ-
ing, but not restricted to, hypertension, coronary artery 
disease (CAD), ischemic heart disease, and CHF or meta-
bolic disease including obesity, metabolic syndrome, insu-
lin resistance, impaired glucose tolerance, and T2DM; and 
(ii) reported any adverse events, defined as an unexpected 
exercise-related response resulting in ill-health, abnormal 
changes in cardiovascular response, or death of an individ-
ual31 or other measures that may compromise safety (includ-
ing electrocardiogram [ECG] changes and biomarkers for 
myocardial damage) during or within the 24-hour period 
following a single session of HIIE. In this instance, HIIE 
was defined as repeated bouts of exercise (of any mode) of 
any duration performed at $80% peak power output or 
$85% VO2peak.
Studies were excluded if they did not report measures 
of blood pressure, heart rate, or measures that indicate myo-
cardial damage or adverse responses (such as vasovagal epi-
sodes) during or immediately after exercise. Authors who 
did not report an adverse event to HIIE were contacted to 
ascertain whether an adverse response was observed and 
not reported or whether an adverse response was simply not 
observed. In the case of more than one publication arising 
from the same study or patient cohort, only the largest study 
was included.
risk of bias. The Cochrane Collaboration’s tool for 
assessing risk of bias was used to assess the methodological 
quality and risk of bias of the included studies in the system-
atic review.32 Individual quality items were investigated using 
a descriptive component approach that included items such 
as the method used to allocate participants into comparable 
groups; blinding of participants/personnel of interventions and 
outcomes; measurement of outcomes in a standard, reliable, 
and valid way; completeness of outcome data for each main 
outcome (including attrition and exclusions from the analysis); 
selective reporting, and any other sources of bias. A summary of 
risk of bias in each study is provided in Table 1. Any disagree-
ment or uncertainty was resolved by discussion and consensus. 
Using this approach, each study was allocated a risk of bias 
rating.
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In view of the heterogeneity in study design, interventions, 
age of patients, medication use, cardiometabolic disease status, 
and outcome measures, we provide a descriptive review rather 
than a meta-analysis of results.
results
A total of 282 studies matching the search criteria were found in 
the literature search. The titles and abstracts of these publications 
were screened and 243 articles were excluded, as they did not 
meet the inclusion criteria (Fig. 1). The full texts of 39 articles 
were retrieved. An additional 28 studies were excluded after 
reading the full text as they did not meet the inclusion crite-
ria. Eleven articles were accepted for the systematic review 
(Table 2). The primary aim of 4 out of the 11 studies was to 
examine different aspects of the cardiovascular response fol-
lowing a single bout of HIIE. Although the cardiovascular 
table 1. risk of bias.
StuDY ADEquAtE 
SEquEnCE 
gEnERAtIon
AlloCAtIon 
ConCEAlMEnt
blInDIng oF 
PARtICIPAntS, 
PERSonnEl, 
AnD outCoME 
ASSESSoRS
InCoMPlEtE 
outCoME 
DAtA 
ADDRESSED
FREE oF 
SElECtIvE 
outCoME 
REPoRtIng
FREE oF 
otHER 
SouRCES 
oF bIAS
gayda et al. 201233 ? ?    
Meyer et al. 201134 ? ?    
guiraud et al. 201335 ? ?    
normandin et al. 201336 n/a n/a    
tomczac et al. 201137 n/a n/a    
guiraud et al. 201038 ? ?    
guiraud et al. 201139 ? ?    
Currie et al. 201240  ?    
Whyte et al.41 ? ?    
gillen et al. 201242 n/a n/a    
tjonna et al. 201143      
notes:  indicates ‘yes’- low risk of bias. ? indicates unclear – not enough information provided in the publication.  indicates ‘no’ – high risk of bias. n/a indicates 
this assessment was not applicable for this study type.
Literature search
Electronic database: Medline, Embase and Cinahl
Full text articles assessed
for eligibility based on
inclusion criteria (n = 13)  
Papers excluded on
title/abstract not
meeting inclusion
criteria (n = 67)   
Papers included in the
systematic review (n = 11) 
Full text articles
excluded not meeting
inclusion criteria (n = 2)  
Review papers
excluded (n = 16) 
Papers identified through database searching (n = 87)
Additional papers
identified by reviewers
from manual search of
reference lists (n = 9)   
Figure 1. Identification, screening, and selection of studies reporting adverse responses to acute high-intensity interval exercise (HIIE) in people with 
cardiometabolic disease.
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response postexercise was not the main scope of the current 
review, these studies were included as they also reported whether 
patients exhibited adverse response during HIIE.
description of the included studies. Eight studies 
examined the effects of HIIE on patients with CVD. Of 
these, five studies involved patients with CHF,33–37 and three 
studies involved patients with coronary heart disease (CHD) 
or CAD.38–40 In addition, three studies examined the effects 
of HIIE on patients with metabolic diseases, including obe-
sity,41 metabolic syndrome,20 and T2DM.42 The sample size of 
the studies ranged between n = 7 and n = 28. As determined 
by the Cochrane Collaboration’s tool for assessing risk of 
bias, the majority of studies included in the systematic review 
reported a moderate risk of bias (Table 1).
Patients. In total, 173 patients took part in the 11 stud-
ies in which 156 patients performed HIIE (age range: 27–66 
years). Studies only included patients who were clinically sta-
ble and treated with appropriate medications. In addition, the 
studies included a wide range of exclusion criteria including 
both relative and absolute contraindications (Table 2).
study protocols. Some protocols (4 of 11 studies) for 
patients with CVD involved exercise on a cycle ergometer. The 
protocols for patients with CHF included several sets (3–10) 
of 30 seconds’ high-intensity exercise followed by 30 seconds 
of active34 or passive33,35,36 recovery. Meyer et al.34 examined 
the effects of four different HIIE protocols on exercise time 
in patients with CHF: interval durations of 30 seconds or 
90 seconds, with active versus passive recovery between bouts 
of exercise. In contrast, the protocol used by Tomczak et al.37 
included exercise on a treadmill consisting of four bouts of 
4-minute duration at 90%–95% of HRmax with 3-minute 
recovery at 70% of HRmax. Similar to the protocols for patients 
with CHF, the protocols for patients with CAD and CHD 
included 15–60 seconds of HIIE followed by a similar dura-
tion of active or passive recovery (1:1 ratio).38–40
In contrast to the protocols used in patients with CVD, 
the protocol used in young overweight/obese patients included 
four sets of 30 seconds’ “all out” sprint with 4.5 minutes’ active 
recovery in between sets.41 In patients with T2DM, Gillen 
et al.42 used a protocol that included 10 bouts of 60 seconds’ 
duration at ∼90% of maximal workload interspersed with 
60-second recovery (1:1 ratio).
supervision level. Five studies did not report the profes-
sional qualifications of the person responsible for supervising 
the exercise sessions. Those that did indicated that the HIIE 
intervention took place at medical or university centers, which 
are likely to be equipped to deal with severe adverse events, 
and under the supervision of a cardiologist, an exercise physi-
ologist, and/or a nurse.33,36–40
Adverse responses. Tomczak et al.37 reported that HIIE 
did not have a negative effect on LV function and two fur-
ther studies reported no adverse responses during HIIE.33,35 
Four studies did not report whether they observed adverse 
responses or not during HIIE39,40,42,43; however, the authors 
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of these studies were contacted and they confirmed that no 
adverse responses were observed during the study (personal 
correspondence). Overall, 13 adverse responses (8%) were 
reported in the 156 individuals who completed the 11 iden-
tified studies. Adverse responses included a vasovagal reac-
tion (n = 2),38 nausea (n = 1),41 ventricular bigeminy (n = 1),37 
a single asymptomatic episode of atrial tachycardia (n = 1),34 
and aphasia and dyspraxia as a result of suspected transient 
cerebral ischemia (n = 1).36 One study reported one case of 
myocardial ischemia, as evident by ST depression .2 mm.34 
Guiraud et al.38 reported that three individuals exhibited ST 
depression and developed mild angina during HIIE. These 
three individuals also developed myocardial ischemia during 
a maximal graded exercise test. A similar study also reported 
that three participants had demonstrable myocardial ischemia 
during HIIE.39
Primary and secondary end points. Five studies assessed 
aspects of safety as the primary aims/end points. One study 
found that the blood pressure response to HIIE was similar to 
that to moderate continuous exercise.33 Two studies reported 
that HIIE had no negative effects on cardiac troponin T, 
C-reactive protein, or brain natriuretic peptide in patients with 
CHD and CHF.36,39 The primary aim of two studies34,38 was 
to examine the effects of different HIIE protocols on exercise 
time to exhaustion in patients with CHD and CHF. No abnor-
mal hemodynamic responses to exercise were observed and it 
was reported that short-duration exercise (15–30 seconds), 
with passive recovery between bouts (1:1 ratio), was more tol-
erable than longer exercise intervals (60–90 seconds), based on 
patients being able to maintain higher exercise percentage of 
VO2peak. In addition, passive recovery between exercise bouts 
increased time to exhaustion compared to active recovery.34,38
In the other six studies (Table 3), safety was a secondary 
end point. Guiraud et al.35 reported that HIIE reduced the 
occurrence of premature ventricular contraction (24-hour 
Holter ECG recording), compared to both MICE, in patients 
with CHF with no adverse events during the exercise. Two 
studies examined the effect of HIIE on endothelial function 
in patients with metabolic syndrome and CAD. Neither study 
reported adverse responses during, nor post, exercise and 
HIIE improved endothelial function to a similar or greater 
extent than MICE.40,43 Similarly, the other two studies did 
not report an adverse response during or post-HIIE, and the 
primary end point was to examine the effects of HIIE on glu-
cose control and insulin sensitivity in obese individuals and 
those with T2DM.41,42
discussion
The current systematic review found that adverse responses to 
HIIE among patients with cardiometabolic diseases enrolled 
in closely supervised studies were around 8%. However, cau-
tion should be taken when translating these findings to all 
patients with cardiometabolic disease due to the small sample 
size, high level of supervision involved, and strict inclusion 
and exclusion criteria applied. Larger randomized-controlled 
studies that are powered to assess safety and include clinically 
complex and older patients are required before a more defini-
tive statement on the safety of HIIE in patients with cardio-
metabolic disease can be made.
Increased physical activity levels can improve func-
tional capacity, quality of life, improve clinical outcomes, and 
potentially reduce mortality in people with cardiometabolic 
diseases.44,45 However, exercise may also transiently increase 
the risk of cardiovascular events, especially at high intensities 
in patients with CVD.4 An important aim of clinical exercise 
prescription is therefore to optimize physiological adaptations 
without placing the patient at risk of exercise-induced events.
To enable inclusion of HIIE in a clinical exercise setting, 
the safety of the protocol must be established. It is crucial to 
demonstrate that any additional health benefit of HIIE train-
ing outweighs any additional risk and that translation of such 
programs from a highly supervised/research-based environ-
ment to the general population is practically possible. In this 
review, we focused on the acute response to HIIE in patients 
with cardiometabolic diseases and not the long-term adapta-
tion that is associated with HIIE training.
sample size and patients selection. To our knowledge, 
there are no large-scale trials that have examined the safety of 
acute HIIE, as a primary end point, for patients with CVD 
and/or metabolic diseases. The sample size of the few stud-
ies that have examined the acute response of these patients to 
HIIE is relatively small (7–28 patients; Table 2). Studies of 
this size are underpowered to determine the risk of adverse 
responses that occur relatively infrequently in patients who are 
medically stable.2 The small sample size across studies makes 
it difficult to (i) reach a meaningful conclusion with regard 
to the physiological/clinical response to the intervention and 
(ii) generalize the results to the wider population with cardio-
metabolic conditions.
Furthermore, the studies reviewed included patients 
who were carefully screened, were clinically stable, and were 
receiving appropriate medication. Each study included a wide 
range of exclusion criteria (Table 2) to reduce the risk associ-
ated with high-intensity exercise.4 As a result, patients, and in 
particular those with CVD/CHF, who attend clinical exercise 
programs may represent a higher-risk cohort than the popula-
tions studied to date. It is also important to note that stud-
ies of the effects of HIIE training have also used a selected 
group of patients, with inclusion/exclusion criteria similar to 
those identified in the current review.16,46,47 This has a par-
ticular relevance for CHF as the median age at the time of 
diagnosis is approximately 76 years of age,48 while the age 
range of patients with CHF in the HIIE studies is 49–61 
years (Table 2). Clearly, the current patient cohorts reported 
in this review do not represent the vast majority of patients in 
the community.
HIIe protocols. There are endless combinations of exer-
cise parameters that can be prescribed in HIIE. Accordingly, 
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table 3. acute effects of hiie.
REFEREnCE bP AnD HR 
DuRIng 
ExERCISE
bIoCHEMICAl 
MARKERS 
oF MuSClE/ 
MYoCARDIAl 
DAMAgE
ADvERSE RESPonSE MAIn FInDIngS MAIn FInDIngS In 
REgARD to SAFEtY
gayda et al. 
201233
normal BP 
response to 
exercise
n/r • No adverse responses.
•  No significant ventricu-
lar arrhythmias and/or 
abnormal BP response 
during exercise.
•  Stroke volume, cardiac 
output and arterio-venous 
difference were similar 
between CMe and hiie. 
•  HIIE was well tolerated 
and safe
•  No significant 
arrhythmias or abnor-
mal BP changes.
Meyer et al. 
201234
n/r n/r •  No significant ventricular 
arrhythmias occurred.
•  N = 1 asymptomatic 
atrial tachycardia, which 
remitted spontaneously 
after 60 sec.
•  N = 1, 2 mm st 
depression.
•  Short duration 30 sec, 
compared to 90 sec, 
interspersed with passive 
recovery interval is bet-
ter tolerated than active 
recovery.
•  No safety issues.
•  HIIE is tolerated in 
stable patients with 
ChF.
guiraud 
et al. 201335
n/r n/r • No adverse responses. •  HIIE increases vagal 
modulation.
•  Post-exercise ave HR was 
lower after hiie vs Con 
or CMe
•  Incidence of premature 
ventricular contractions 
were reduced post hiie vs 
Con and CMe.
•  HIIE is safe for patients 
with ChF.
normandin 
et al. 201336
hr similar 
between CMe 
and hiie
serum
cardiac tro-
ponin t, CrP 
or BnP did not 
change after 
hiie.
•  N = 1: Female age 77 
documented ischemic 
cardiomyopathy. 12–24h 
after hiie developed 
aphasia and dyspraxia 
(3 hrs) diagnosed 
with transitorycerebral 
ischemia. Full recovery 
after treatment with 
clopidogrel.
•  No other adverse events 
were recorded.
•  No significant ventricular 
arrhythmias and/or 
abnormal BP response.
•  Serum cardiac troponin T 
unchanged after hiie.
•  No significant increase 
in CrP and BnP post-
exercise.
•  HIIE appears to be safe.
•  HIIE completed 
without occurrence of 
arrhythmias, myocardial 
injury, or cardiac 
decompensation.
tomczak 
et al. 201137
hr = 96% 
hrmax no 
control group 
for comparison
n/r •  N = 1# withdrew due 
to claustrophobia from 
outcome measure.
•  N = 1# dizziness 
during exercise testing 
(terminated at 64% 
predicted hrmax), but 
completed remaining 
exercise tests symptom 
free.
•  N = 1 developed 
ventricular bigeminy 
during hiie. 
•  LV function was main-
tained or improved imme-
diately post hiie.
•  HIIE is safe in a 
supervised medical 
setting.
•  HIIE does not increase 
ChF symptoms. 
guiraud 
et al. 201038
n/r n/r •  N = 2 vagal reaction 
following hiie.
•  N = 3 Myocardial 
ischemia (st segment 
depression) on eCg and 
developed mild angina 
during hiie. 
•  Passive recovery between 
sets resulted in longer 
time to exhaustion while 
maintaining high time 
spent at high %Vo2 max.
•  15 sec intervals may be 
more appropriate than 
60 sec intervals.
•  HIIE appears to be 
safe in stable, fit, 
well-selected patients 
with Chd.
*guiraud 
et al. 201139
n/r no difference 
in cardiac 
troponin t 
between CMe 
and hiie.
•  N = 3 myocardial 
ischemia (st segment 
depression ,2 mm) 
during hiie.
•  Participants reported HIIE 
as the preferred exercise 
compared to CMe
•  HIIE was safe in patients 
who exercise regularly
•  HIIE appears to be 
safe for selected stable 
patients with Chd who 
exercise regularly.
(Continued)
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table 3. (Continued)
REFEREnCE bP AnD HR 
DuRIng 
ExERCISE
bIoCHEMICAl 
MARKERS 
oF MuSClE/ 
MYoCARDIAl 
DAMAgE
ADvERSE RESPonSE MAIn FInDIngS MAIn FInDIngS In 
REgARD to SAFEtY
*Currie et al. 
201240
hr: was 
similar 
between hiie 
and CMe
n/r • No adverse responses •  Endothelial-dependent 
dilation was improved post 
hiie
•  No conclusion in regard 
to the safety of hiie.
Whyte et al. 
201341
n/r n/r •  N = 1 nausea during hiie. 
Patient did not complete 
the session.
•  Extended sprint increased 
insulin sensitivity both 
immediately and 24 h 
post-exercise.
•  SIT increased insulin sen-
sitivity 24h after exercise 
only compared to control.
•  No conclusion in regard 
to the safety of hiie.
•  Authors indicated that 
safety studies are 
needed.
*gillen et al. 
201242
n/r n/r • No adverse responses •  HIIE improved glycaemic 
control in patients with 
t2dM.
•  No conclusion in regard 
to the safety of hiie.
*tjonna 
et al. 201143
n/r n/r • No adverse responses •  Endothelial function 
improved post-exercise
•  BP and blood glucose 
were reduced after hiie.
•  No safety data were 
provided.
notes: *indicates studies that did not report an adverse event and were contacted to clarify whether an adverse event occurred and was not reported in the study.
#indicates that the physiological response was not included as an adverse response caused as a result of hiit.
Abbreviations: BnP, Brain natriuretic peptide; BP, blood pressure; Chd, coronary heart disease; ChF, chronic heart failure; CMe, continues moderate exercise; 
Con, control; CrP, C reactive proteins; eCg, electrocardiography; hiie, high intensity interval exercise; lV, left ventricular; n/r, not reported; sit, sprint interval 
training; CVd, cardiovascular disease; hr, heart rate; t2dM, type 2 diabetes mellitus.
it is important to identify the optimal protocol/s for each clini-
cal population. It has been shown that short exercise intervals 
(15–30 seconds), followed by 15–30 seconds’ passive recovery 
(1:1 ratio), may be better tolerated compared to longer interval 
times (60–90 seconds). Furthermore, in patients with CHD 
and CHF, passive recovery seems to be superior to active 
recovery in terms of total exercise time to exhaustion and to 
be equal in terms of work at .85% of VO2peak.34,38 As such, it 
appears that for patients with CVD, the combination of short 
intervals with passive recovery is better tolerated and, thus, 
may increase long-term exercise participation. However, it 
remains to be determined which HIIE protocol elicits supe-
rior long-term improvements in clinically relevant end points 
in these populations.
One study prescribed four bouts of 4-minute duration at 
90%–95% of HRpeak with 3-minute active recovery between 
intervals,37 which is similar to the protocols used by Rognmo 
et al.17 and Wisloff et al.16 However, given the absence of a 
control group, it is hard to assess whether this protocol is supe-
rior to other protocols in terms of safety. It is important to 
acknowledge that in all studies, the rate of adverse responses 
was low, and the HIIE sessions were well tolerated overall 
across all populations (Table 3). From a practical point of 
view, the selection of a HIIE protocol should be similar to the 
selection of any other exercise training protocols and should 
include consideration of risk versus benefits. It should also be 
based on case-by-case consideration of exercise prescription 
and not a “one-size fits all” model.
supervision level. There is general agreement across the 
studies reviewed that HIIE should be performed in facili-
ties that have both the equipment and the expertise to han-
dle severe adverse responses. Most studies reported that the 
exercise was performed in medical or university centers and 
under the supervision of a cardiologist, an exercise physiolo-
gist, and/or a nurse.33,36–39 As such, it is still unclear whether 
HIIE should be performed in community facilities or at home, 
where equipment and/or medical personnel may not be avail-
able to deal with adverse events. Due to the potential risk of 
HIIE4 and the lack of detailed trials investigating the “actual” 
risk of this type of exercise as a primary end point, caution 
needs to be taken and it is therefore recommended that an 
experienced clinical exercise physiologist should supervise 
this type of exercise prescription. In addition, extra care must 
be taken in monitoring signs and symptoms during and post-
HIIE, especially in sedentary individuals. We recommend 
that blood pressure be observed regularly during and postex-
ercise. In addition, it may be beneficial to use a 12-lead ECG 
in patients with cardiometabolic diseases before, during, and 
post-HIIE to monitor arrhythmias and myocardial ischemia 
as these are the most prevalent adverse events reported during 
exercise in these populations (Table 3).
Adverse responses. Exercise at mild, moderate, and 
vigorous (up to 80% of peak capacity) intensities are safe 
for appropriately screened patients with cardiometabolic 
diseases.1 This is important as the higher the exercise intensity, 
the higher is the increase in the myocardial oxygen demand 
Levinger et al
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(as measured by the rate–pressure product: heart rate × sys-
tolic blood pressure), which may increase the risk of myo-
cardial ischemia and MI.49 Indeed, it has been reported that 
4.4% of patients who exhibited acute MI were performing 
heavy physical exertion (.6 METs [metabolic equivalent]) 
in the hour prior to the event and that the risk for acute MI 
in the subsequent hour after heavy physical exertion is 5.9 
times higher compared to light or no exertion.50 Furthermore, 
men with low levels of habitual activity have a 56% increase 
in relative risk of cardiac arrest during or immediately postex-
ercise, compared with that at other times and the relative risk 
is reduced to 5% among men at the highest level of habitual 
activity.51 As such, it appears prudent that individuals should 
perform moderate-intensity physical activity, on a regular 
basis, before they engage in HIIE.
HIIE appears to have no adverse effect on LV function37; 
indeed, long-term HIIE training may in fact improve LV func-
tion.16 In addition, most studies reported no adverse responses 
during or following HIIE.33,37,39,40,42,43 However, overall 13 
adverse responses were reported across the studies that were 
included in the current review. Adverse responses were related 
to myocardial ischemia, arrhythmias, vagal reactions, and nausea. 
One patient experienced aphasia and dyspraxia as a result of tran-
sient cerebral ischemia 12–24 hours postexercise; however, it was 
not clear whether this response was related to the exercise. It is 
important to note that although the rate of adverse events was 
8% during or following HIIE, most of the adverse responses were 
mild in nature. This emphasizes the importance of close supervi-
sion during and following this form of exercise.
Although the current review did not assess the incidence 
of adverse response/events during HIIE training, it is impor-
tant to note that the event rates that were reported during 
training interventions are generally low.16,27,46 However, it has 
recently been reported that the rates of complications (cardiac 
arrest) during and immediately post-HIIE training was 1 per 
23,182 hours compared to 1 per 129,456 hours of moderate-
intensity exercise, suggesting a five times higher rate of car-
diac arrest during HIIE compared to that during MICE.28 
As such, caution must be taken and detailed screening assess-
ments must be performed before prescribing HIIE to patients 
with cardiometabolic disease.
Limitations. The current review has some potential limi-
tations. First, the number of patients (n = 156) who partici-
pated in HIIE is relatively small and as such, more research 
should be conducted before it will be possible to conclusively 
advocate for or against this form of exercise to be included in 
routine clinical practice. Second, due to the low number of 
available studies reporting adverse responses to a single bout 
of HIIE, we included studies on patients with a variety of car-
diometabolic disease, including CHF, CHD, CAD, obesity, 
T2DM, and metabolic syndrome. Given the heterogeneity of 
both the patient population and the HIIE protocols used, the 
results on adverse responses should be translated with caution. 
This further highlights the requirement for more studies to 
evaluate the safety of HIIE protocols in patients with cardio-
metabolic disease.
In conclusion, the current review indicates that the inci-
dence of adverse responses during or within 24 hours post-
HIIE in patients with cardiometabolic diseases is around 8%, 
which is somewhat higher compared to the previously reported 
risk during MICE. As such, caution must be taken when 
prescribing HIIE to patients with cardiometabolic disease. 
Patients who wish to perform HIIE should be clinically stable, 
have had recent exposure to at least regular moderate-intensity 
exercise, and have appropriate supervision and monitoring dur-
ing and after the exercise session.
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